CD8A and neoplasm: To determine potential effector molecules impacting the enhanced fitness of tumor-specific CD8+ T cells in Fgl2-deficient mice, we next phenotypically and functionally characterized OT-I from healthy and tumor-bearing WT versus Fgl2–/– mice.